American Journal of Cardiovascular Drugs

Am J Cardiovasc Drugs

1175-3277

1179-187X

Therapeutic Area

Cardiology, Pharmacology, Vascular Medicine

Academics, Cardiologists, Cardiovascular Surgeons, Caregivers, Critical Care Nurses, Critical Care Physicians, Electrophysiologists, Emergency Nurses, Emergency Physicians, Family Practice Physicians, General Practitioners, Geriatricians, Healthcare Executives, Internists, Interventionalists, Nurse Practitioners, Nurse Practitioners/Physician Assistants, Patients, Pediatricians, Pharmacists, Pharmacologists, Physicians, Primary Care Physicians, Researchers, Vascular Medicine Specialists, Vascular Surgeons

The American Journal of Cardiovascular Drugs promotes rational therapy and effective patient management within the discipline of cardiology by providing a regular program of independent review articles covering all aspects of the management of cardiovascular disorders, particularly the place in therapy of newer and established agents and procedures. The journal includes: - Short overviews of contentious or emerging issues (Current Opinions and Leading Articles, respectively). - Comprehensive narrative reviews on therapeutic approaches to managing cardiovascular disease. - Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. - Therapy in practice reviews covering optimum management of specific conditions. - Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in cardiovascular medicine. - Original research articles reporting the results of well-designed clinical studies, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic studies. Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in the American Journal of Cardiovascular Drugs may be accompanied by plain language summaries to assist readers in understanding important medical advances. All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication. Promoting rational therapy within the discipline of cardiology, the American Journal of Cardiovascular Drugs covers all aspects of the treatment of cardiovascular disorders, particularly the place in therapy of newer and established agents. Via a program of reviews and original clinical research articles, the journal addresses major issues relating to treatment of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of cardiovascular disorders; and the practical management of specific clinical situations. The journal Also offers the ability to create digital features as well as host them.

International Academy of Cardiovascular Sciences

Adis, part of Springer Nature

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines